Pharmaron Beijing Co Ltd (300759.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100003JW4
Pharmaron Beijing Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 12.28 bn CNY | 14.10 bn CNY |
| Gross profit | 4.18 bn CNY | 4.91 bn CNY |
| Operating income | 2.10 bn CNY | 2.22 bn CNY |
| EBIT | 1.72 bn CNY | 2.11 bn CNY |
| Net income | 1.79 bn CNY | 1.66 bn CNY |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Pharmaron Beijing Co Ltd
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
More stocks
- Evercore Inc. (EVR)
- QXO, Inc. (QXO)
- Guangdong Haid Group Co Ltd (002311.SZ)
- Aier Eye Hospital Group (300015.SZ)
- WH Group Ltd (288.HK)
- Allwyn AG (ALWN.AT)
- Avantor, Inc. (AVTR)
- Shoprite Holdings Ltd (SHP.JO)
- AES Corporation (AES)
- Fidelity National Financial, Inc. (FNF)
- Goertek Inc (002241.SZ)
- Absa Group Ltd (ABG.JO)
Not investment advice. All data without warranty, price as of 15.10.2026. Details in the risk notice.